AAA
PBYI icon

Affinity Asset Advisors’s Puma Biotechnology PBYI Stock Holding History

Affinity Asset Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-250,000
Closed -$638K – 102
2024
Q3 		$638K Hold
250,000
– – 0.1% 75
2024
Q2 		$815K Buy
+250,000
New +$1.1M 0.13% 83
2024
Q1 		– Sell
-202,349
Closed -$876K – 123
2023
Q4 		$876K Hold
202,349
– – 0.17% 70
2023
Q3 		$532K Hold
202,349
– – 0.17% 71
2023
Q2 		$714K Buy
202,349
+25,000
+14% +$78K 0.28% 58
2023
Q1 		$548K Buy
+177,349
New +$669K 0.21% 65

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return